Otsu, Japan

Makoto Urushitani


Average Co-Inventor Count = 3.4

ph-index = 1


Company Filing History:


Years Active: 2015-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Makoto Urushitani

Introduction

Makoto Urushitani is a notable inventor based in Otsu, Japan. He has made significant contributions to the field of medical science, particularly in the development of diagnostic agents for neurological diseases. With a total of 2 patents, his work is recognized for its innovative approach to addressing complex health issues.

Latest Patents

Urushitani's latest patents include groundbreaking inventions. The first patent focuses on an antibody fragment that degrades and removes abnormal TDP-43. This modified antibody fragment is capable of binding to misfolded TDP-43 and includes a chaperone-mediated autophagy localizing signal peptide. The second patent involves an imaging diagnostic agent and extracorporeal diagnostic agent for incurable neurological diseases. This invention features a curcumin derivative containing a fluorine atom, which is designed to diagnose diseases associated with amyloid β peptide aggregates.

Career Highlights

Makoto Urushitani is affiliated with Shiga University of Medical Science, where he conducts research and develops innovative solutions in medical diagnostics. His work has garnered attention for its potential impact on the diagnosis and treatment of neurological disorders.

Collaborations

Urushitani collaborates with esteemed colleagues, including Yoshitaka Tamaki and Ikuo Tooyama. Their combined expertise contributes to the advancement of research in their field.

Conclusion

Makoto Urushitani's contributions to medical science through his patents and research are invaluable. His innovative approaches to diagnosing neurological diseases highlight the importance of continued research and development in this critical area of health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…